PubMed

Short-course prophylaxis against tuberculosis in HIV-infected persons. A decision and cost-effectiveness analysis.

Rose DN.

Ann Intern Med. 1998 Nov 15;129(10):779-86.PMID: 9841583 [PubMed - indexed for MEDLINE]Related articlesFree article

Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS, the Adult AIDS Clinical Trials Group, the Pan American Health Organization, and the Centers for Disease Control and Prevention Study Group.

Gordin F, Chaisson RE, Matts JP, Miller C, de Lourdes Garcia M, Hafner R, Valdespino JL, Coberly J, Schechter M, Klukowicz AJ, Barry MA, O'Brien RJ.

JAMA. 2000 Mar 15;283(11):1445-50.PMID: 10732934 [PubMed - indexed for MEDLINE]Related articlesFree article

Monitored isoniazid prophylaxis for low-risk tuberculin reactors older than 35 years of age: a risk-benefit and cost-effectiveness analysis.

Salpeter SR, Sanders GD, Salpeter EE, Owens DK.

Ann Intern Med. 1997 Dec 15;127(12):1051-61.PMID: 9412307 [PubMed - indexed for MEDLINE]Related articlesFree article

Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a multicenter clinical trial.

Jasmer RM, Saukkonen JJ, Blumberg HM, Daley CL, Bernardo J, Vittinghoff E, King MD, Kawamura LM, Hopewell PC; Short-Course Rifampin and Pyrazinamide for Tuberculosis Infection (SCRIPT) Study Investigators.

Ann Intern Med. 2002 Oct 15;137(8):640-7.PMID: 12379063 [PubMed - indexed for MEDLINE]Related articlesFree article

[Effectiveness and problems of PZA-containing 6-month regimen for the treatment of new pulmonary tuberculosis patients]

Wada M.

Kekkaku. 2001 Jan;76(1):33-43. Review. Japanese. PMID: 11211781 [PubMed - indexed for MEDLINE]Related articles

Costs and cost-effectiveness of four treatment regimens for latent tuberculosis infection.

Holland DP, Sanders GD, Hamilton CD, Stout JE.

Am J Respir Crit Care Med. 2009 Jun 1;179(11):1055-60. Epub 2009 Mar 19.PMID: 19299495 [PubMed - indexed for MEDLINE]Related articles

The cost-effectiveness of preventing AIDS-related opportunistic infections.

Freedberg KA, Scharfstein JA, Seage GR 3rd, Losina E, Weinstein MC, Craven DE, Paltiel AD.

JAMA. 1998 Jan 14;279(2):130-6. Erratum in: JAMA 1999 Jun 2;281(21):1989. PMID: 9440663 [PubMed - indexed for MEDLINE]Related articlesFree article

A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration.

Whalen CC, Johnson JL, Okwera A, Hom DL, Huebner R, Mugyenyi P, Mugerwa RD, Ellner JJ.

N Engl J Med. 1997 Sep 18;337(12):801-8.PMID: 9295239 [PubMed - indexed for MEDLINE]Related articlesFree article

[Evaluation of 2 tuberculosis chemoprophylaxis regimens in patients infected with human immunodeficiency virus. The GECMEI Group]

Martínez Alfaro EM, Cuadra F, Solera J, Maciá MA, Geijo P, Sánchez Martínez PA, Rodríguez Zapata M, Largo J, Sepúlveda MA, Rosa C, Sánchez L, Espinosa A, Mateos F, Blanch JJ.

Med Clin (Barc). 2000 Jul 1;115(5):161-5. Spanish. PMID: 10996870 [PubMed - indexed for MEDLINE]Related articles

[The effectiveness of pyrazinamide-containing six-month short course chemotherapy]

Wada M.

Kekkaku. 2000 Nov;75(11):665-73. Japanese. PMID: 11140090 [PubMed - indexed for MEDLINE]Related articles

Tuberculosis preventive therapy for HIV-infected people in sub-Saharan Africa is cost-effective.

Bell JC, Rose DN, Sacks HS.

AIDS. 1999 Aug 20;13(12):1549-56.PMID: 10465080 [PubMed - indexed for MEDLINE]Related articles

Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a cost-effectiveness analysis based on a multicenter clinical trial.

Jasmer RM, Snyder DC, Saukkonen JJ, Hopewell PC, Bernardo J, King MD, Kawamura LM, Daley CL; Short-Course Rifampin and Pyrazinamide for Tuberculosis Infection Study Investigators.

Clin Infect Dis. 2004 Feb 1;38(3):363-9. Epub 2004 Jan 13.PMID: 14727206 [PubMed - indexed for MEDLINE]Related articles

Twelve months of isoniazid compared with four months of isoniazid and rifampin for persons with radiographic evidence of previous tuberculosis: an outcome and cost-effectiveness analysis.

Jasmer RM, Snyder DC, Chin DP, Hopewell PC, Cuthbert SS, Antonio Paz E, Daley CL.

Am J Respir Crit Care Med. 2000 Nov;162(5):1648-52.PMID: 11069790 [PubMed - indexed for MEDLINE]Related articlesFree article

Completing tuberculosis prophylaxis in jail: targeting treatment and comparison of rifampin/pyrazinamide with isoniazid regimens.

Lincoln T, Brannan GL, Lynch V, Conklin TJ, Clancey T, Rose DN, Tuthill RJ.

Int J Tuberc Lung Dis. 2004 Mar;8(3):306-11.PMID: 15139468 [PubMed - indexed for MEDLINE]Related articles

Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid. Tuberculosis Trials Consortium.

Vernon A, Burman W, Benator D, Khan A, Bozeman L.

Lancet. 1999 May 29;353(9167):1843-7.PMID: 10359410 [PubMed - indexed for MEDLINE]Related articles

Preventing Mycobacterium avium complex in patients who are using protease inhibitors: a cost-effectiveness analysis.

Bayoumi AM, Redelmeier DA.

AIDS. 1998 Aug 20;12(12):1503-12.PMID: 9727572 [PubMed - indexed for MEDLINE]Related articles

Treatment of lymph node tuberculosis--a randomized clinical trial of two 6-month regimens.

Jawahar MS, Rajaram K, Sivasubramanian S, Paramasivan CN, Chandrasekar K, Kamaludeen MN, Thirithuvathas AJ, Ananthalakshmi V, Prabhakar R.

Trop Med Int Health. 2005 Nov;10(11):1090-8.PMID: 16262733 [PubMed - indexed for MEDLINE]Related articlesFree article

Safety and completion rate of short-course therapy for treatment of latent tuberculosis infection.

Cook PP, Maldonado RA, Yarnell CT, Holbert D.

Clin Infect Dis. 2006 Aug 1;43(3):271-5. Epub 2006 Jun 22.PMID: 16804838 [PubMed - indexed for MEDLINE]Related articles

Controlled clinical trial of 4 short-course regimens of chemotherapy (three 6-month and one 8-month) for pulmonary tuberculosis: final report. East and Central African/British Medical Research Council Fifth Collaborative Study.

[No authors listed]

Tubercle. 1986 Mar;67(1):5-15.PMID: 3521015 [PubMed - indexed for MEDLINE]Related articles

Controlled clinical trial of 4 short-couse regimens of chemotherapy (three 6-month and one 8-month) for pulmonary tuberculosis.

[No authors listed]

Tubercle. 1983 Sep;64(3):153-66.PMID: 6356538 [PubMed - indexed for MEDLINE]Related articles